FDA
-
-
-
-
-
-
-
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against BioNTech, Mobileye, BioVie, and ADM and Encourages Investors to Contact the Firm
-
-
-
-
-
-
-
BIONTECH INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In BioNTech To Contact Him Directl
-
-
-
-
-
-
-
BioNTech SE (BNTX) September call option implied volatility flat
-
-
-
-
-
-
-
FDA Authorizes Changes to Simplify Use of Bivalent mRNA COVID-19 Vaccines
-
-
-
-
-
-
-
Pfizer and BioNTech Submit sBLA for U.S. FDA Approval of Omicron BA.4/BA.5-Adapted Bivalent COVID-19 Vaccine for Ages 12 Years and Older as Primary Series or Booster
-
-
-
-
-
-
-
Pfizer and BioNTech Receive U.S. FDA Emergency Use Authorization for Omicron BA.4/BA.5-Adapted Bivalent COVID-19 Vaccine in Children Under 5 Years
-
-
-
-
-
-
-
Pfizer and BioNTech Advance Next-Generation COVID-19 Vaccine Strategy with Study Start of Candidate Aimed at Enhancing Breadth of T cell Responses and Duration of Protection
-
249,371 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All